Troup and colleagues [10] found that a greater number of ER-positive tumors (n = 99) compared with ER-negative tumors (n = 6) had lumican protein expression ≥ 25th percentile among 140 women with breast cancer (P = 0.002). This evidence concerns the gene ESR1 and breast carcinoma.